Has anyone dealt with tirzepatide dual agonism: gip + glp-1 synergistic mechanism?

NicoleRaleigh said:

If you are going to change something, change one thing and give it long enough to express itself.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. Pushing back on the consensus forming here. Consistency is not the same as correctness, and a board that agrees with itself quickly is usually agreeing with the first person who sounded certain.

NicoleRaleigh said:

If you are going to change something, change one thing and give it long enough to express itself.

No disagreement, though the timescale matters more than the mechanism here. Most of what looks like a difference in kind turns out to be a difference in how long somebody waited.

NicoleRaleigh said:

If you are going to change something, change one thing and give it long enough to express itself.

This answered a question I did not know how to ask. Sending this to two other people who asked me the same thing last week.

Clinical perspective, offered as context rather than as advice. Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third retelling.

Closing the loop on my own question.

Closing this out: the trough rather than the peak explains the pattern I was seeing on day six, which I had been blaming on the vial.